These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 34609787

  • 1. Management of submacular massive haemorrhage in age-related macular degeneration: comparison between subretinal transplant of human amniotic membrane and subretinal injection of tissue plasminogen activator.
    Caporossi T, Bacherini D, Governatori L, Oliverio L, Di Leo L, Tartaro R, Rizzo S.
    Acta Ophthalmol; 2022 Aug; 100(5):e1143-e1152. PubMed ID: 34609787
    [Abstract] [Full Text] [Related]

  • 2. The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF.
    Treumer F, Wienand S, Purtskhvanidze K, Roider J, Hillenkamp J.
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1115-1123. PubMed ID: 28280989
    [Abstract] [Full Text] [Related]

  • 3. Fundus Autofluorescence Patterns in Subretinal Hemorrhages Associated with Neovascular Age-Related Macular Degeneration.
    Nawrocka ZA, Nawrocki J.
    Ophthalmologica; 2024 Jun; 247(1):58-64. PubMed ID: 38113868
    [Abstract] [Full Text] [Related]

  • 4. Displacement of Submacular Hemorrhage Using Subretinal Cocktail Injection versus Pneumatic Displacement: A Real-World Comparative Study.
    Szeto SKH, Tsang CW, Mohamed S, Lee GKY, Lok JKH, Hui VWK, Tsang KK, Chen LJ, Brelen M, Lai TYY.
    Ophthalmologica; 2024 Jun; 247(2):118-132. PubMed ID: 38408445
    [Abstract] [Full Text] [Related]

  • 5. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.
    Chang W, Garg SJ, Maturi R, Hsu J, Sivalingam A, Gupta SA, Regillo CD, Ho AC.
    Am J Ophthalmol; 2014 Jun; 157(6):1250-7. PubMed ID: 24531021
    [Abstract] [Full Text] [Related]

  • 6. Tissue plasminogen activator-assisted vitrectomy for submacular hemorrhage due to age-related macular degeneration.
    Gok M, Karabaş VL, Aslan MS, Kara Ö, Karaman S, Yenihayat F.
    Indian J Ophthalmol; 2017 Jun; 65(6):482-487. PubMed ID: 28643713
    [Abstract] [Full Text] [Related]

  • 7. Pneumatic Displacement of Submacular Hemorrhage with Subretinal Air and Tissue Plasminogen Activator: Initial United States Experience.
    Sharma S, Kumar JB, Kim JE, Thordsen J, Dayani P, Ober M, Mahmoud TH.
    Ophthalmol Retina; 2018 Mar; 2(3):180-186. PubMed ID: 31047581
    [Abstract] [Full Text] [Related]

  • 8. Comparison between different techniques for treatment of submacular haemorrhage due to Age-Related Macular Degeneration.
    Kishikova L, Saad AAA, Vaideanu-Collins D, Isac M, Hamada D, El-Haig WM.
    Eur J Ophthalmol; 2021 Sep; 31(5):2621-2624. PubMed ID: 32993349
    [Abstract] [Full Text] [Related]

  • 9. PREDICTORS OF 3-MONTH AND 1-YEAR VISUAL OUTCOMES AFTER VITRECTOMY WITH SUBRETINAL TISSUE PLASMINOGEN ACTIVATOR INJECTION FOR SUBMACULAR HEMORRHAGE.
    Miki M, Miyata M, Ooto S, Tamura H, Ueda-Arakawa N, Muraoka Y, Miyake M, Hata M, Takahashi A, Kido A, Kogo T, Uji A, Tsujikawa A.
    Retina; 2023 Nov 01; 43(11):1971-1979. PubMed ID: 37490778
    [Abstract] [Full Text] [Related]

  • 10. Subretinal Transplant of Human Amniotic Membrane in Advanced Age-Related Macular Degeneration.
    Caporossi T, Scampoli A, Baldascino A, Gambini G, Pacini B, Governatori L, Bacherini D, Carlà MM, Crincoli E, Rizzo C, Kilian R, Rizzo S.
    Life (Basel); 2022 Nov 30; 12(12):. PubMed ID: 36556364
    [Abstract] [Full Text] [Related]

  • 11. Prognostic factors for visual acuity improvement after treatment of submacular hemorrhage secondary to exudative age-related macular degeneration.
    Barayev E, Tiosano A, Zlatkin R, Elul R, Dotan A, Hadayer A, Gal-Or O, Ehrlich R.
    Eur J Ophthalmol; 2024 May 30; 34(3):825-833. PubMed ID: 37715632
    [Abstract] [Full Text] [Related]

  • 12. Comparison of subretinal versus intravitreal injection of recombinant tissue plasminogen activator with gas for submacular hemorrhage secondary to wet age-related macular degeneration: treatment outcomes and brief literature review.
    Tranos P, Tsiropoulos GN, Koronis S, Vakalis A, Asteriadis S, Stavrakas P.
    Int Ophthalmol; 2021 Dec 30; 41(12):4037-4046. PubMed ID: 34331185
    [Abstract] [Full Text] [Related]

  • 13. Subretinal coapplication of recombinant tissue plasminogen activator and bevacizumab for neovascular age-related macular degeneration with submacular haemorrhage.
    Treumer F, Klatt C, Roider J, Hillenkamp J.
    Br J Ophthalmol; 2010 Jan 30; 94(1):48-53. PubMed ID: 19946027
    [Abstract] [Full Text] [Related]

  • 14. Early surgical displacement of submacular hemorrhage without tissue plasminogen activator use: one-year outcomes.
    Abdulaal M, Donkor R, Robertson J, Lewis S, Miller DG, Schartman J, Platt S, Coney JM.
    Can J Ophthalmol; 2024 Oct 30; 59(5):e582-e589. PubMed ID: 37925165
    [Abstract] [Full Text] [Related]

  • 15. Gravitational displacement of submacular haemorrhage in patients with age-related macular disease.
    Erdogan G, Kirmaci A, Perente I, Artunay O.
    Eye (Lond); 2020 Jun 30; 34(6):1136-1141. PubMed ID: 31792350
    [Abstract] [Full Text] [Related]

  • 16. Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): study protocol for a phase 3, pan-European, two-group, non-commercial, active-control, observer-masked, superiority, randomised controlled surgical trial.
    Jackson TL, Bunce C, Desai R, Hillenkamp J, Lee CN, Lois N, Peto T, Reeves BC, Steel DH, Edwards RT, van Meurs JC, Wafa H, Wang Y.
    Trials; 2022 Jan 31; 23(1):99. PubMed ID: 35101110
    [Abstract] [Full Text] [Related]

  • 17. Pars plana vitrectomy and subretinal tissue plasminogen activator for large exudative submacular hemorrhage: a case series.
    Patikulsila D, Winaikosol P, Choovuthayakorn J, Watanachai N, Chaikitmongkol V, Kunavisarut P.
    BMC Ophthalmol; 2022 Oct 27; 22(1):411. PubMed ID: 36303103
    [Abstract] [Full Text] [Related]

  • 18. Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration.
    Haupert CL, McCuen BW, Jaffe GJ, Steuer ER, Cox TA, Toth CA, Fekrat S, Postel EA.
    Am J Ophthalmol; 2001 Feb 27; 131(2):208-15. PubMed ID: 11228297
    [Abstract] [Full Text] [Related]

  • 19. OPTICAL COHERENCE TOMOGRAPHY FINDINGS AND SURGICAL OUTCOMES OF TISSUE PLASMINOGEN ACTIVATOR-ASSISTED VITRECTOMY FOR SUBMACULAR HEMORRHAGE SECONDARY TO AGE-RELATED MACULAR DEGENERATION.
    Hirashima T, Moriya T, Bun T, Utsumi T, Hirose M, Oh H.
    Retina; 2015 Oct 27; 35(10):1969-78. PubMed ID: 26079475
    [Abstract] [Full Text] [Related]

  • 20. [Pars plana vitrectomy, subretinal injection of recombinant tissue plasminogen activator and fluid-gas exchange in the management of massive submacular hemorrhages secondary to age-related macular degeneration].
    Auriol S, Mahieu L, Lequeux L, Quintyn JC, Pagot-Mathis V.
    J Fr Ophtalmol; 2010 Feb 27; 33(2):84-91. PubMed ID: 20092910
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.